Health

Generative AI helps to design new drug candidates

● AI models, not dissimilar to ChatGPT in the field of languages, are designing new compounds and speeding up the pharmaceutical industry’s quest to develop new drugs.
● Building on traditional research and existing test data, the new AIs enable laboratories to gain time and optimise drug candidates’ chances of success in clinical trials.
● Deploying the power of reinforcement learning, the new machines can take into account innumerable parameters and evaluate the eligibility of compounds in just a few milliseconds.
Read the article

Vyntelligence: Video Notes for Operators in the Field

Read the article

ADHD, oximetry… Smartphones and virtual reality are revolutionising diagnostics

Read the article
GettyImages - VR XR

Start-ups: virtual reality breaks new ground in digital therapeutics

Read the article

Hugo Dinh: “We are only at the beginning of digital diagnostics”

Read the article
lab scientists / scientifiques dans un laboratoire

Medicine: will soft robots soon be used inside the human body?

Read the article
Femtech

FemTech wants to reduce the gender gap in healthcare

Read the article